Explore the Potential with AI-Driven Innovation
The focused library is created on demand with the latest virtual screening and parameter assessment technology, supported by the Receptor.AI drug discovery platform. This method is more effective than traditional methods and results in higher-quality compounds with better activity, selectivity, and safety.
From a virtual chemical space containing more than 60 billion molecules, we precisely choose certain compounds. Our collaborator, Reaxense, aids in their synthesis and provision.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
We employ our advanced, specialised process to create targeted libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our methodology employs molecular simulations to explore a wide array of proteins, capturing their dynamic states both individually and within complexes. Through ensemble virtual screening, we address conformational mobility, uncovering binding sites within functional regions and remote allosteric locations. This thorough exploration ensures no potential mechanism of action is overlooked, aiming to discover novel therapeutic targets and lead compounds across an extensive spectrum of biological functions.
Our library is unique due to several crucial aspects:
partner
Reaxense
upacc
P46108
UPID:
CRK_HUMAN
Alternative names:
Proto-oncogene c-Crk; p38
Alternative UPACC:
P46108; A8MWE8; B0LPE8; D3DTH6; Q96GA9; Q96HJ0
Background:
The Adapter molecule crk, also known as Proto-oncogene c-Crk and p38, plays a pivotal role in cellular processes such as branching, adhesion, and motility. It is central to the BCAR1-CRK-RAPGEF1 signaling pathway, leading to RAP1 activation. Furthermore, it regulates cell adhesion and migration through MAPK8 activation and interacts with DOCK1 and DOCK4 to mediate phagocytosis of apoptotic cells and cell motility.
Therapeutic significance:
Understanding the role of Adapter molecule crk could open doors to potential therapeutic strategies.